MoonLake Immunotherapeutics

The current price of MLTX is 42.49 USD — it has increased by 0.57% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MoonLake Immunotherapeutics stocks are traded under the ticker MLTX.

MoonLake Immunotherapeutics is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.

MLTX stock is 2.11% volatile and has beta coefficient of 2.07. Check out the list of the most volatile stocks — is MoonLake Immunotherapeutics there?

MLTX earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.23 USD resulting in a 21.86% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about MoonLake Immunotherapeutics earnings.

Yes, you can track MoonLake Immunotherapeutics financials in yearly and quarterly reports right on TradingView.

MLTX stock has risen by 0.52% compared to the previous week, the month change is a 15.16% fall, over the last year MoonLake Immunotherapeutics has showed a 104.28% increase.

Today MoonLake Immunotherapeutics has the market capitalization of ‪2.67 B‬, it has decreased by 5.70% over the last week.

No, MLTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, MLTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MoonLake Immunotherapeutics stock right from TradingView charts — choose your broker and connect to your account.

MLTX reached its all-time high on Feb 12, 2024 with the price of 64.98 USD, and its all-time low was 4.25 USD and was reached on May 16, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 29, 2024, the company has 50.00 employees. See our rating of the largest employees — is MoonLake Immunotherapeutics on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MoonLake Immunotherapeutics technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MoonLake Immunotherapeutics stock shows the neutral signal. See more of MoonLake Immunotherapeutics technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on MoonLake Immunotherapeutics future price: according to them, MLTX price has a max estimate of 100.00 USD and a min estimate of 55.00 USD. Read a more detailed MoonLake Immunotherapeutics forecast: see what analysts think of MoonLake Immunotherapeutics and suggest that you do with its stocks.